Other OTC - Delayed Quote • USD
Lotus Pharmaceuticals, Inc. (LTUS)
At close: April 23 at 3:33 PM EDT
Key Executives
Amounts are as of December 31, 2010 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Zhong Yi Liu | Founder, Chairman, Chief Executive Officer and President | 180k | -- | 1961 |
| Ms. Yan Zeng | Chief Financial Officer and Principal Accounting Officer | -- | -- | 1969 |
| Dr. Xing Shen | Vice President of Corporate Development | -- | -- | 1971 |
Lotus Pharmaceuticals, Inc.
813 Blue Ridge Drive
Suite 198
Nashville, TN 37207
United States
- Sector:
- Financial Services
- Industry: Shell Companies
- Full Time Employees:
- 233
Description
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.
Corporate Governance
Lotus Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available